Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT06581432

Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations

Led by Boehringer Ingelheim · Updated on 2026-04-29

430

Participants Needed

88

Research Sites

220 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a study for people with advanced cancer for whom previous treatment was not successful. Adults aged 18 and over with advanced cancer with HER2 alterations can join the study. The purpose of this study is to find out whether a medicine called zongertinib helps people with advanced cancers with HER2 alterations. HER2 alterations can cause cancer. Zongertinib inhibits HER2. Participants are put into groups based on the type of advanced cancer they have, the type of HER2 alterations they have, and the dose of zongertinib they receive. Depending on the group they are in, participants take 1 of 2 different doses of zongertinib each day. Participants can continue the treatment as long as they benefit from it and can tolerate it. Participants visit the study site regularly. During many of the visits, the doctors check the size of the tumour and whether it has spread to other parts of the body. During all the visits, the doctors check participants' health and take note of any unwanted effects.

CONDITIONS

Official Title

Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Signed and dated written informed consent before joining the trial
  • Age 18 years or older (or legal age of consent if higher in your country)
  • Documented HER2 status showing HER2 amplification or known activating HER2 mutations
  • Willingness to provide a sample of archival tumor tissue for testing
  • Histologically or cytologically confirmed locally advanced unresectable or metastatic solid tumor
  • Had at least one prior line of therapy for metastatic disease
  • Investigator's opinion that further standard therapy is unlikely to provide meaningful benefit or be tolerated
Not Eligible

You will not qualify if you...

  • Diagnosis of HER2 mutant Non-small cell lung cancer (NSCLC)
  • Previous or current malignancies other than the one treated in this trial within the past 3 years, except effectively treated non-melanoma skin cancers, carcinoma in situ of the cervix, ductal carcinoma in situ of the breast, localized prostate cancer under surveillance, or other effectively treated cured malignancies
  • Need or desire to continue restricted medications or drugs that could interfere with trial safety
  • Not fully recovered from major surgery performed before screening or planned within 6 months after screening

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 88 locations

1

Alaska Oncology and Hematology, LLC

Anchorage, Alaska, United States, 99508

Actively Recruiting

2

University of Arizona Comprehensive Cancer Center

Tucson, Arizona, United States, 85719

Not Yet Recruiting

3

Precision NextGen Oncology

Beverly Hills, California, United States, 90212

Actively Recruiting

4

Scripps Cancer Center Torrey Pines

La Jolla, California, United States, 92037

Not Yet Recruiting

5

Valkyrie Clinical Trials

Los Angeles, California, United States, 90067

Actively Recruiting

6

Yale University School of Medicine

New Haven, Connecticut, United States, 06511

Actively Recruiting

7

BRCR Global

Tamarac, Florida, United States, 33321

Actively Recruiting

8

Illinois Cancer Specialists

Arlington Heights, Illinois, United States, 60005

Not Yet Recruiting

9

Community MD Anderson Cancer Center - East Medical Oncology

Indianapolis, Indiana, United States, 46219

Actively Recruiting

10

Maryland Oncology Hematology, Columbia

Columbia, Maryland, United States, 21044

Not Yet Recruiting

11

Karmanos Cancer Institute

Detroit, Michigan, United States, 48201

Not Yet Recruiting

12

Presbyterian Healthcare Services

Albuquerque, New Mexico, United States, 87110

Not Yet Recruiting

13

Icahn School of Medicine at Mount Sinai

New York, New York, United States, 10029

Actively Recruiting

14

Memorial Sloan-Kettering Cancer Center

New York, New York, United States, 10065

Actively Recruiting

15

Taylor Cancer Research Center

Maumee, Ohio, United States, 43537

Not Yet Recruiting

16

Alliance Cancer Specialists, PC, Wynnewood

Wynnewood, Pennsylvania, United States, 19096

Not Yet Recruiting

17

Sarah Cannon Research Institute at Mary Crowley

Dallas, Texas, United States, 75230

Not Yet Recruiting

18

The University of Texas MD Anderson Cancer Center

Houston, Texas, United States, 77030

Actively Recruiting

19

Texas Oncology - Plano West

Plano, Texas, United States, 75093

Not Yet Recruiting

20

Virginia Cancer Specialists, PC

Fairfax, Virginia, United States, 22031

Actively Recruiting

21

Macquarie University

Macquarie Park, New South Wales, Australia, 2109

Actively Recruiting

22

GenesisCare North Shore

St Leonards, New South Wales, Australia, 2065

Actively Recruiting

23

Princess Alexandra Hospital

Woolloongabba, Queensland, Australia, 4102

Actively Recruiting

24

St John of God Subiaco Hospital

Subiaco, Western Australia, Australia, 6008

Actively Recruiting

25

Cancer Research South Australia

Adelaide, Australia

Not Yet Recruiting

26

Cliniques Universitaires Saint-Luc

Brussels, Belgium, 1200

Actively Recruiting

27

Edegem - UNIV UZ Antwerpen

Edegem, Belgium, 2650

Actively Recruiting

28

Cross Cancer Institute (University of Alberta)

Edmonton, Alberta, Canada, T6G 1Z2

Actively Recruiting

29

BC Cancer Agency - Vancouver

Vancouver, British Columbia, Canada, V5Z 4E6

Not Yet Recruiting

30

Princess Margaret Cancer Centre

Toronto, Ontario, Canada, M5G 2M9

Actively Recruiting

31

Centre Hospitalier de l'Universite de Montreal (CHUM)

Montreal, Quebec, Canada, H2X 0A9

Not Yet Recruiting

32

McGill University Health Centre (MUHC)

Montreal, Quebec, Canada, H4A 3J1

Not Yet Recruiting

33

Peking University First Hospital

Beijing, China, 100034

Not Yet Recruiting

34

Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine

Hangzhou, China, 310016

Not Yet Recruiting

35

Anhui Provincial Cancer Hospital

Hefei, China, 230001

Not Yet Recruiting

36

The First Affiliated Hospital of Nanchang University

Nanchang, China, 330006

Actively Recruiting

37

Shanghai East Hospital

Shanghai, China, 200120

Actively Recruiting

38

Shanghai GoBroad Cancer Hospital

Shanghai, China, 200131

Not Yet Recruiting

39

Wuhan Union Hospital

Wuhan, China, 430022

Not Yet Recruiting

40

Henan Cancer Hospital

Zhengzhou, China, 450008

Actively Recruiting

41

INS Bergonie

Bordeaux, France, 33000

Actively Recruiting

42

CTR Georges-François Leclerc

Dijon, France, 21079

Actively Recruiting

43

CTR Leon Berard

Lyon, France, 69373

Not Yet Recruiting

44

HOP Timone

Marseille, France, 13385

Not Yet Recruiting

45

HOP la Milétrie

Poitiers, France, 86000

Actively Recruiting

46

Institut Gustave Roussy

Villejuif, France, 94805

Actively Recruiting

47

Charité - Universitätsmedizin Berlin

Berlin, Germany, 12203

Not Yet Recruiting

48

Justus-Liebig Universität Gießen

Giessen, Germany, 35392

Actively Recruiting

49

Asklepios Kliniken GmbH & Co. KGaA

Hamburg, Germany, 22763

Actively Recruiting

50

Universität Leipzig

Leipzig, Germany, 04103

Actively Recruiting

51

Universitätsklinikum Mannheim GmbH

Mannheim, Germany, 68167

Actively Recruiting

52

Klinikum rechts der Isar der Technischen Universität München

München, Germany, 81675

Not Yet Recruiting

53

Az. Ospedaliere Umberto I di Ancona

Ancona, Italy, 60020

Actively Recruiting

54

Centro di riferimento Oncologico

Aviano (PN), Italy, 33081

Not Yet Recruiting

55

Istituto Scientifico Romagnolo

Meldola (FC), Italy, 47014

Actively Recruiting

56

ASST Grande Ospedale Metropolitano Niguarda

Milan, Italy, 20162

Actively Recruiting

57

AOU Università degli Studi della Campania Luigi Vanvitelli

Naples, Italy, 80131

Actively Recruiting

58

Fondazione Policlinico Universitario Campus Bio-medico

Rome, Italy, 00128

Not Yet Recruiting

59

Aichi Cancer Center Hospital

Aichi, Nagoya, Japan, 464-8681

Actively Recruiting

60

National Cancer Center Hospital East

Chiba, Kashiwa, Japan, 277-8577

Actively Recruiting

61

Kyushu University Hospital

Fukuoka, Fukuoka, Japan, 812-8582

Not Yet Recruiting

62

Hokkaido University Hospital

Hokkaido, Sapporo, Japan, 060-8648

Not Yet Recruiting

63

Okayama University Hospital

Okayama, Okayama, Japan, 700-8558

Not Yet Recruiting

64

Osaka International Cancer Institute

Osaka, Osaka, Japan, 541-8567

Actively Recruiting

65

Shizuoka Cancer Center

Shizuoka, Sunto-gun, Japan, 411-8777

Actively Recruiting

66

National Cancer Center Hospital

Tokyo, Chuo-ku, Japan, 104-0045

Actively Recruiting

67

Japanese Foundation for Cancer Research

Tokyo, Koto-ku, Japan, 135-8550

Actively Recruiting

68

Nederlands Kanker Instituut

Amsterdam, Netherlands, 1066 CX

Actively Recruiting

69

Radboud Universitair Medisch Centrum

Nijmegen, Netherlands, 6525 GL

Actively Recruiting

70

Oslo Universitetssykehus HF, Radiumhospitalet

Oslo, Norway, N-0379

Actively Recruiting

71

Pan American Center for Oncology Trials, LLC

Rio Piedras, Puerto Rico, 00935

Actively Recruiting

72

National Cancer Centre Singapore

Singapore, Singapore, 168583

Not Yet Recruiting

73

Seoul National University Hospital

Seoul, South Korea, 03080

Actively Recruiting

74

Severance Hospital

Seoul, South Korea, 03722

Actively Recruiting

75

Asan Medical Center

Seoul, South Korea, 05505

Actively Recruiting

76

Samsung Medical Center

Seoul, South Korea, 135-710

Actively Recruiting

77

Complejo Hospitalario Universitario A Coruña

A Coruña, Spain, 15006

Actively Recruiting

78

Hospital Germans Trias i Pujol

Badalona, Spain, 08916

Not Yet Recruiting

79

Hospital del Mar

Barcelona, Spain, 08003

Actively Recruiting

80

Hospital Universitari Vall d'Hebron

Barcelona, Spain, 08035

Actively Recruiting

81

Hospital Duran i Reynals

Barcelona, Spain, 08908

Not Yet Recruiting

82

Clínica Universidad de Navarra - Madrid

Madrid, Spain, 28027

Actively Recruiting

83

Hospital Clínico San Carlos

Madrid, Spain, 28040

Actively Recruiting

84

Clínica Universidad de Navarra

Pamplona, Spain, 31008

Actively Recruiting

85

Hospital Virgen del Rocío

Seville, Spain, 41013

Actively Recruiting

86

Hospital Clinico De Valencia (INCLIVA)

Valencia, Spain, 46010

Not Yet Recruiting

87

Ninewells Hospital & Medical School

Dundee, United Kingdom, DD1 9SY

Not Yet Recruiting

88

The Christie Hospital

Manchester, United Kingdom, M20 4BX

Not Yet Recruiting

Loading map...

Research Team

B

Boehringer Ingelheim

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here